Dr Gabrielle Campbell presented at the NDARC Webinar Series on Thursday 17 November, 2022.
This webinar reported on opioid dependence in chronic non-cancer pain from the five-year Pain and Opioids IN Treatment (POINT) study.
The Pain and Opioids IN Treatment (POINT) study was a 5-year NHMRC funded study to examine the benefits and outcomes of pharmaceutical opioids in chronic non-cancer pain management. This presentation provided a focus on the prevalence of opioid dependence in people with chronic non-cancer pain, the impact of different definitions on identifying people with opioid dependence, risk factors associated with opioid dependence and the dynamic nature of opioid dependence in people with chronic non-cancer pain.
About the speaker
Gabrielle Campbell is a Senior Research Fellow at the University of Queensland. She was a previous recipient of an NHMRC Australian Public Health Early Career Fellowship (2017-2021) and also worked previously at the National Drug and Alcohol Research Centre (NDARC) and holds an Adjunct Senior Lecturer appointment there. Gabrielle's research interests include pharmaceutical opioids, opioid dependence and suicidal behaviours amongst people living with chronic non-cancer pain. She coordinated a large prospective study examining the benefits and outcomes of prescription opioids for chronic pain, the Pain and Opioids IN Treatment (POINT) study.